De novo Powered Air-Purifying Respirator Design and Fabrication for Pandemic Response.
Journal
medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986
Informations de publication
Date de publication:
29 Mar 2021
29 Mar 2021
Historique:
entrez:
6
4
2021
pubmed:
7
4
2021
medline:
7
4
2021
Statut:
epublish
Résumé
The rapid spread of COVID-19 and disruption of normal supply chains resulted in severe shortages of personal protective equipment (PPE), particularly devices with few suppliers such as powered air-purifying respirators (PAPRs). A scarcity of information describing design and performance criteria represents a substantial barrier to new approaches to address these shortages. We sought to apply open-source product development to PAPRs to enable alternative sources of supply and further innovation. We describe the design, prototyping, validation, and user testing of locally manufactured, modular, PAPR components, including filter cartridges and blower units, developed by the Greater Boston Pandemic Fabrication Team (PanFab). Two designs, one with a fully custom-made filter and blower unit housing, and the other with commercially available variants (the "Custom" and "Commercial" designs respectively) were developed. Engineering performance of the prototypes was measured and safety validated using NIOSH-equivalent tests on apparatus available under pandemic conditions, at university laboratories. Feedback on designs was obtained from four individuals, including two clinicians working in an ambulatory clinical setting and two research technical staff for whom PAPR use is a standard part of occupational PPE. Respondents rated the PanFab Custom PAPR a 4 to 5 on a 5 Likert-scale 1) as compared to current PPE options, 2) for the sense of security with use in a clinical setting, and 3) for comfort. The three other versions of the designs (with a commercial blower unit, filter, or both) performed favorably, with survey responses consisting of scores ranging from 3-5. Engineering testing and clinical feedback demonstrate that the PanFab designs represents favorable alternative PAPRs in terms of user comfort, mobility, and sense of security. A nonrestrictive license promotes innovation in respiratory protection for current and future medical emergencies.
Identifiants
pubmed: 33821290
doi: 10.1101/2021.03.25.21252076
pmc: PMC8020994
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NCI NIH HHS
ID : P30 CA006516
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA225088
Pays : United States
Commentaires et corrections
Type : UpdateIn
Références
J Am Acad Dermatol. 2020 May;82(5):1215-1216
pubmed: 32171808
J Am Acad Dermatol. 2021 Feb;84(2):554-556
pubmed: 32592881
BMC Biomed Eng. 2021 Jun 7;3(1):10
pubmed: 34099062
J Eur Acad Dermatol Venereol. 2020 Jul;34(7):e297-e298
pubmed: 32302444
Front Digit Health. 2021 Mar;3:
pubmed: 33899045
Am J Infect Control. 2009 Dec;37(10):e5-e16
pubmed: 20004810
Am J Public Health. 2020 Aug;110(8):1162-1164
pubmed: 32552025
Am J Infect Control. 2008 May;36(4):276-82
pubmed: 18455048
BMC Infect Dis. 2021 Jul 29;21(1):712
pubmed: 34325673
Am J Infect Control. 2012 May;40(4):375-80
pubmed: 21864945
Anesth Analg. 2010 Oct;111(4):933-45
pubmed: 20810676